Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Classical hematology 4 Myeloid 1 Gynecologic 1

Conditions

Myeloproliferative Disorders 1

Interventions

Blood Specimen Collection 15 Imatinib Mesylate 10 Flow Cytometry 10 nilotinib 8 Surveys and Questionnaires 8 Polymerase Chain Reaction 8 ponatinib 6 Cytogenetic Analysis 6 ruxolitinib 5 bosutinib 5 Psychiatric Rehabilitation 5 Dasatinib 5 Therapeutics 4 Interviews as Topic 4 Biopsy 4 asciminib 3 Observation 3 Microarray Analysis 3 In Situ Hybridization, Fluorescence 3 Immunoenzyme Techniques 3 Amplified Fragment Length Polymorphism Analysis 3 olverembatinib 2 fludarabine 2 Watchful Waiting 2 Tyrosine Kinase Inhibitors 2 Molecular Diagnostic Techniques 2 Influenza Vaccines 2 Immunologic Techniques 2 Immunohistochemistry 2 Hydroxyurea 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × apixaban × Myeloid × Clear all

NCT04192916 2021-02-21

MPN-DOACs

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡